Duker indicated that EyePoint expects to report top line data for the Phase III LUGANO trial in mid-2026 with LUCIA data to follow closely, complete enrollment in the pivotal Phase III DME program in ...

Dr Daniel Polya, an expert from Royal Australian and New Zealand College of Ophthalmologists’, explained that it's ‘so important to see an optician when a floater first appears’. The eye expert ...

Dear Doctors: You recently stated in a column about eye floaters that there is no cure at this time. I got a vitrectomy for this condition, and it was life-changing for me. By no means is this ...

When light enters the eye through the lens, specific cells on the retina are activated. As floaters move within the vitreous body, they cast shadows on the retina, creating the odd shapes many people ...

At Envision Summit 2026, the “Fast and Fundus” retina panel delivered rapid-fire case discussions grounded in practical decision-making. Moderated by Maria Berrocal, MD, the session moved from ...

By Kamal Choudhury Feb 17 (Reuters) - Ocular Therapeutix's experimental eye drug showed superiority to Regeneron's Eylea in a key late-stage trial, but its modest advantage and higher rates of certain ...

What is retinal detachment and how is it linked to severe myopia? Experts break down why it happens, the telltale symptoms and why urgent treatment is critical.

Ocular Therapeutix (NASDAQ:OCUL) stock fell 25% Tuesday after the company reported top-line results from its Phase 3 SOL-1 superiority trial for Axpaxli in wet age-related macular degeneration (AMD).

Sports-related injuries are extremely common in every eye doctor’s practice. These injuries are more common in younger ...

Cataract surgery in the highly myopic patient, typically defined by an axial length greater than 26 mm, represents one of the most demanding scenarios in refractive cataract surgery.While these ...